| NCT05539872 | Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers | COMPLETED | PHASE2, PHASE3 | 2022-08-22 | 2023-01-30 | 2023-01-29 |
| NCT04207840 | Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals | COMPLETED | PHASE4 | 2019-12-09 | 2019-12-23 | 2019-12-20 |
| NCT02271334 | Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers | COMPLETED | PHASE2 | 2014-08 | 2015-03 | 2014-10 |
| NCT02210806 | Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation | COMPLETED | PHASE2 | 2014-07 | 2014-10 | 2014-09 |
| NCT01737892 | Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults | TERMINATED | PHASE1, PHASE2 | 2012-11 | 2012-11 | 2012-11 |
| NCT01737905 | Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma | COMPLETED | PHASE3 | 2012-10 | 2013-12 | 2013-03 |
| NCT01689363 | Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP) | COMPLETED | PHASE2 | 2012-09 | 2012-12 | 2012-11 |
| NCT01581177 | Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation | COMPLETED | PHASE2 | 2012-04 | 2012-08 | 2012-07 |
| NCT01476904 | Safety Study in Adolescent and Adult Patients With Asthma | COMPLETED | PHASE3 | 2011-11 | 2012-07 | 2012-04 |
| NCT01460511 | Evaluation of Efficacy and Safety of E004 in Children With Asthma | COMPLETED | PHASE3 | 2011-10 | 2012-07 | 2012-03 |
| NCT01357642 | Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients | COMPLETED | PHASE3 | 2011-07 | 2011-12 | 2011-11 |
| NCT01255709 | Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS | COMPLETED | PHASE2 | 2010-12 | 2011-01 | 2011-01 |
| NCT01188577 | Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics | COMPLETED | PHASE1, PHASE2 | 2010-08 | 2011-01 | 2010-09 |
| NCT01189396 | Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006 | COMPLETED | PHASE2 | 2010-07 | 2011-01 | 2010-12 |
| NCT01174732 | Dose-Ranging Study of A006 DPI, in Adult Asthma Patients | COMPLETED | PHASE2 | 2010-07 | 2011-01 | 2010-10 |
| NCT01143051 | Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers | COMPLETED | PHASE1, PHASE2 | 2010-01 | 2010-06 | 2010-06 |
| NCT01025648 | Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients. | TERMINATED | PHASE1, PHASE2 | 2009-12 | 2009-12 | 2009-12 |
| NCT00634517 | 4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma | TERMINATED | PHASE3 | 2008-03 | 2008-12 | 2008-12 |
| NCT00634829 | Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction | TERMINATED | PHASE3 | 2008-02 | 2008-10 | 2008-10 |
| NCT00635505 | Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients | TERMINATED | PHASE3 | 2007-09 | 2008-08 | 2008-08 |